References
- S Stone et al., “Results of a time and motion study of two next-generation sequencing workflows in a routine oncology biomarker profiling setting,” Poster G066, presented at the Association of Molecular Pathology Annual Meeting (2025).
Sponsored By
| Category | Detail |
|---|---|
| Condition | Next-Generation Sequencing (NGS) in Precision Oncology |
| Key Mechanisms | Automation and workflow redesign to enhance efficiency and reduce turnaround time. |
| Target Population | Patients requiring precision oncology testing for solid tumors. |
| Care Setting | Laboratory settings conducting NGS testing. |
Patients with solid tumors requiring precision oncology testing.
Precision oncology enables individualized treatment based on NGS results.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
February 8, 2022
3 min read
Using AI to enhance personalized healthcare for patients with prostate cancer
February 28, 2022
1 min read
Genomics and computational pathology can take rare disease diagnostics to the next level
March 4, 2022
2 min read
Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics
April 7, 2022
3 min read
Molecular pathology is complex – and the benefits of keeping it local are extensive
Affiliations:
Specialties:
Areas of Expertise: